{"name":"SQZ Biotech","slug":"sqz","ticker":"SQZ","exchange":"NYSE","domain":"sqzbiotech.com","description":"SQZ Biotech is a biotech company focused on cell therapy engineering. The company is developing novel cell therapies for various indications, including cancer and autoimmune diseases. SQZ has a strong pipeline of products in development, with several candidates in clinical trials. As a leader in the cell therapy engineering space, SQZ is well-positioned to capitalize on the growing demand for cell-based therapies.","hq":"Watertown, MA","founded":0,"employees":"","ceo":"Howard Bernstein","sector":"Biotech / Cell Therapy Engineering","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$80M","metrics":{"revenue":21478000,"revenueGrowth":-20.7,"grossMargin":0,"rdSpend":70984000,"netIncome":-79464000,"cash":99900000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"SQZ-EPF patent cliff ($100M at risk)","drug":"SQZ-EPF","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"SQZ Biotech Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"SQZ Biotech reported its financial results for the fourth quarter and full year 2023, with revenue of $10.2 million and a net loss of $43.8 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"SQZ Biotech Announces Collaboration with Merck to Develop Novel Cell Therapies","summary":"SQZ Biotech announced a collaboration with Merck to develop novel cell therapies for various indications, including cancer and autoimmune diseases.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5ha1lsQnphUTZJT0hCVzFkai1oWVJYT3lDWXAzeUFTS2xtRGhhS3AxV3c2X2Q2Vl9TNGZWekpBb1N3bjM1bHRvYkVIWGN6NGwxNlh0X21FOXdwa1phN0pNWTM4VmpxNk5wY25GeWVpYmx2NnRQNFp5am5GSE1adw?oc=5","date":"2024-05-01","type":"pipeline","source":"Life Science Leader","summary":"Where Are They Now? SQZ Biotech - Life Science Leader","headline":"Where Are They Now? SQZ Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNNWJEVHV0UGYteXZsWGdzNWpZYnM2cVdtRk9lSEtBWHgxbU9lRmcwM2VIRkdHUkx5X3R5OUtVdkhRbFQ4bTNjZURVOERjN0VnMVVHdXlXOThGb2x0ZUFTRktQelhFMFo1YllVd3N0a2VGaHR6cHg0RDlLSTR6M2xNZUJpY2tITEFhdXZwckxWV0ZfdmNNdFE?oc=5","date":"2024-03-26","type":"pipeline","source":"BioPharma Dive","summary":"SQZ, Portal founder Armon Sharei on starting over in biotech - BioPharma Dive","headline":"SQZ, Portal founder Armon Sharei on starting over in biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaXRpa3FtOVp2aF9kVXU5XzczUHlucHNUTXBtTHAzRzRwMFMzOGk5cHVyNTZ4VGw4d1NrZUhuNm9rQWhsbEFiNUNVb3kxWExxYzdoeDlxbjdfVGlnTTBQR1RJTXo1cFUxYnNoZjNVWE1HeXpVeUFtYlZ0VlhwVkdfcWhUbVZwemtCRUlYT2kyellEQmtpX0kyVU90WnVySklRRlQ0dEE4M1JBTk93QndzQlhNc2p3bG5BRm40?oc=5","date":"2024-03-01","type":"pipeline","source":"Fierce Biotech","summary":"SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell - Fierce Biotech","headline":"SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNV1BBZ2gwaVhyREZRNmNGMC1KMkRtTTlvYjNsVzliTjk3TGZGTzBKN0VSeG14Yko4OEIwWmZUaHRtMHlVZ0gxRXlCTzMxUE54c2N5ZDdWd2hONWV4YW05Wmk2QXVST3RZNl9BUHRfTHFiUHdIQjJtMTN2VWtmeWxOb0VGNnkzaUpLRGZtSlJoVWNvbXJtUE5qc1RFcmlpMWdzU2JhNGpB?oc=5","date":"2024-03-01","type":"deal","source":"Business in Vancouver","summary":"Vancouver’s Stemcell continues American biotech buying spree - Business in Vancouver","headline":"Vancouver’s Stemcell continues American biotech buying spree","sentiment":"neutral"},{"date":"2023-12-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-11-08","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2023-10-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-09-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNSVlfeTJ3WktHRWhKU1RaNWozaHFXdlFyMjIwUEl1QUhqVm1EbVZ6bnZaQjR2amIybXYxREtFWWtEYzFldnQ4elp1MjNLQTZKcnNpR0xFTXRia3dLdnhfcWFvOE5qc29NYWdlM0VMNkxmWkNsMTlPNEJUQXdZWTV3TzRKQnpFak9wTzB1T3RaQ0pHUXJYc0xTNEhESWtrM3NxSFZyWGI3bGVTZw?oc=5","date":"2023-09-07","type":"pipeline","source":"Pharma Voice","summary":"‘Not all rainbows and unicorns’ — a former CEO dishes on his rocky biotech ride - Pharma Voice","headline":"‘Not all rainbows and unicorns’ — a former CEO dishes on his rocky biotech ride","sentiment":"neutral"},{"date":"2023-08-10","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPaVlnVFAwdG1odV9HZUVCOENFdkEyTThWYzFScDg2VkdjdURzYzJMOUp5UlZqaEF5VHJ2WTJHQkFYQkRTOWZpa3hzODJ1dmR6RGRlZkVVdVB3WS1iS0syaG1nSGhvRF9lcXhkU3RhM2pRelQzbHF3RjdNZnBDV1FFeGV1V2FMWlQzS01FbnAzMlFEY29tVWZwelAzWWdGLUNubjlTT3BQYjR3UEtHTmV5RFFzQXRHaE9iaG1UWQ?oc=5","date":"2023-07-25","type":"deal","source":"Business Wire","summary":"SQZ Biotechnologies Provides Update on Collaboration with Roche - Business Wire","headline":"SQZ Biotechnologies Provides Update on Collaboration with Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOUVg1RWhCbVlvcEwtVHRBbFk2Um11S3ZubGZkNGxwM3Q2NE94Zi1RbUlXRkxYeDQ4X0tRNllqUWFsTE5uVjBhOEdDaUF1ZzBod0dVOVliS1ZqYUNOSmptT2IyZkV4WnNvVDg2dVh1eW9zaUc5cFlUb012Y2NLOVlDSm5hS3Q4YWJ2OE9DczZadFhGVEpTSnlrWVRTdks3di1kNUVkYkxYZ25zTk1sMWdVaS04ZVNaaUNMbHpYT2FwZTUzZ0k?oc=5","date":"2023-07-25","type":"pipeline","source":"Pharmaceutical Technology","summary":"Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch - Pharmaceutical Technology","headline":"Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch","sentiment":"neutral"},{"date":"2023-07-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-07-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-07-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[{"drugName":"SQZ-EPF","drugSlug":"sqz-epf","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Editas Medicine","CRISPR Therapeutics","Bluebird Bio"],"therapeuticFocus":["Oncology","Autoimmune Diseases"],"financials":{"source":"sec_edgar+yahoo","revenue":21478000,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":21478000,"period":"2022-12-31"},{"value":27098000,"period":"2021-12-31"},{"value":27098000,"period":"2021-12-31"},{"value":20998000,"period":"2020-12-31"},{"value":20998000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":70984000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-79464000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":99900000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}